Source: BioPortfolio

viDA: viDA Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Updated 27022017 Prices from USD $250

SummaryviDA Therapeutics Inc viDA focuses on the discovery and development of therapeutics for the treatment of autoimmune and chronic inflammatory diseases. The company's lead product candidate VTI1002 is in a topical formulation for the treatment of Disc...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Alistair Duncan's photo - President & CEO of viDA

President & CEO

Alistair Duncan

CEO Approval Rating

79/100

Read more